Dmitriy Akimovich Kharagezov
Research Subjects
Dmitriy Akimovich Kharagezov has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Anton Grigor'EVich Milakin
National Medical Research Centre for Oncology
19 shared publications - Ellada A. Mirzoyan
National Medical Research Centre for Oncology
18 shared publications - Oleg Nikolaevich Stateshnyy
National Medical Research Centre for Oncology
17 shared publications - Igor' Aleksandrovich Leyman
National Medical Research Centre for Oncology
15 shared publications - Yuriy Nikolaevich Lazutin
National Medical Research Centre for Oncology
12 shared publications - K. D. Iozefi
National Medical Research Centre for Oncology
9 shared publications
Latest Publications
- 15 June 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 6,p. 108-112
Congenital intrathoracic accessory spleen: a case report
Accessory spleen is a rare anomaly occurring in approximately 10% of people. Most often, accessory spleen can be located in spleen gate. However, localization in parenchymal abdominal organs, retroperitoneal space, pelvis and chest is also possible. Congenital accessory spleen is extremely rare, and only several cases are described in the literature. Diagnosis causes some difficulties. CT-based differentiation with malignant tumor is difficult. We present a 72-year-old patient with congenital intrathoracic accessory spleen.
- 15 June 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 6,p. 108-112
Congenital intrathoracic accessory spleen: a case report
Accessory spleen is a rare anomaly occurring in approximately 10% of people. Most often, accessory spleen can be located in spleen gate. However, localization in parenchymal abdominal organs, retroperitoneal space, pelvis and chest is also possible. Congenital accessory spleen is extremely rare, and only several cases are described in the literature. Diagnosis causes some difficulties. CT-based differentiation with malignant tumor is difficult. We present a 72-year-old patient with congenital intrathoracic accessory spleen.
- Open Access
- 21 September 2025
- Published by Publishing House ABV Press in MD-Onco
- Vol. 5 (3) , 94-102
Dendritic cell vaccines for lung cancer: current status and development prospects. Literature review
This paper presents a literature review on the use of dendritic cell vaccines for lung cancer, prepared based on the analysis of sources from domestic and foreign literature presented in electronic databases of scientific medical literature PabMed, eLIBRARY.RU. The analysis included publications characterizing the current capabilities of laboratory, instrumental and molecular genetic methods for obtaining and using dendritic cell vaccines for lung cancer.The aim of the work – to highlight the results of international and domestic studies on the production, screening and use of dendritic cell vaccines, as well as immunotherapy strategies for lung cancer.
- 21 September 2025
- Published by Publishing House ABV Press in MD-Onco
- Vol. 5 (3) , 94-102
Open AccessDendritic cell vaccines for lung cancer: current status and development prospects. Literature review
This paper presents a literature review on the use of dendritic cell vaccines for lung cancer, prepared based on the analysis of sources from domestic and foreign literature presented in electronic databases of scientific medical literature PabMed, eLIBRARY.RU. The analysis included publications characterizing the current capabilities of laboratory, instrumental and molecular genetic methods for obtaining and using dendritic cell vaccines for lung cancer.The aim of the work – to highlight the results of international and domestic studies on the production, screening and use of dendritic cell vaccines, as well as immunotherapy strategies for lung cancer.
- Open Access
- 9 June 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (2) , 41-48
Tactics of preventive correction of critical respiratory failure in patients with resectable forms of lung cancer in combination with chronic obstructive pulmonary disease
The article describes clinical examples of the effectiveness of preventive puncture-dilatation tracheostomy (PDT) in preventing critical respiratory complications and improving the immediate results of radical surgical treatment of patients with severe manifestations of chronic obstructive pulmonary disease (COPD) and resectable forms of lung cancer (LC). According to the generalized literature data, the incidence of LC and COPD is 72.8 % among the male population and 52.5 % among women. The combination of LC and COPD causes a significant decrease in respiratory reserves in cancer patients, which leads to an increase in the frequency of complications and an increased risk of death during their treatment. For resectable forms, LC surgical treatment involves removal or resection of the lung, which reduces the total area of the respiratory surface of the lung tissue and oxygen supply to the lungs. These changes are accompanied by a critical violation of the ventilation-perfusion ratio, i.e. alveolar ventilation and cardiac output with an aggravation of hypoxia. This situation is most dangerous for patients with COPD, who after radical surgery have an aggravation of obstructive manifestations in the lungs with an already initially altered gas exchange. As a result, insufficient oxygen enrichment of the organs leads to a cascade of uncontrolled reactions with an intensification of lipid peroxidation and an imbalance in the antioxidant system with fatal consequences for the patient. These clinical examples demonstrate the obvious advantage of preventive PDT, which allows timely changes in the tactics of respiratory support in the early postoperative period and treatment in general (clinical example 1). Routine PDT allows avoiding emergency measures to replace the respiratory function with reintubation, and the use of adapted intelligent artificial lung ventilation modes eliminates additional sedation, muscle relaxation and analgesia in patients LC with severe forms of COPD. Clinical case 2 shows that emergency replacement of the patient's respiratory function has significant difficulties in terms of treatment and prognosis of the course of the disease, and increases the duration of his stay in the intensive care unit.
- 9 June 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (2) , 41-48
Open AccessTactics of preventive correction of critical respiratory failure in patients with resectable forms of lung cancer in combination with chronic obstructive pulmonary disease
The article describes clinical examples of the effectiveness of preventive puncture-dilatation tracheostomy (PDT) in preventing critical respiratory complications and improving the immediate results of radical surgical treatment of patients with severe manifestations of chronic obstructive pulmonary disease (COPD) and resectable forms of lung cancer (LC). According to the generalized literature data, the incidence of LC and COPD is 72.8 % among the male population and 52.5 % among women. The combination of LC and COPD causes a significant decrease in respiratory reserves in cancer patients, which leads to an increase in the frequency of complications and an increased risk of death during their treatment. For resectable forms, LC surgical treatment involves removal or resection of the lung, which reduces the total area of the respiratory surface of the lung tissue and oxygen supply to the lungs. These changes are accompanied by a critical violation of the ventilation-perfusion ratio, i.e. alveolar ventilation and cardiac output with an aggravation of hypoxia. This situation is most dangerous for patients with COPD, who after radical surgery have an aggravation of obstructive manifestations in the lungs with an already initially altered gas exchange. As a result, insufficient oxygen enrichment of the organs leads to a cascade of uncontrolled reactions with an intensification of lipid peroxidation and an imbalance in the antioxidant system with fatal consequences for the patient. These clinical examples demonstrate the obvious advantage of preventive PDT, which allows timely changes in the tactics of respiratory support in the early postoperative period and treatment in general (clinical example 1). Routine PDT allows avoiding emergency measures to replace the respiratory function with reintubation, and the use of adapted intelligent artificial lung ventilation modes eliminates additional sedation, muscle relaxation and analgesia in patients LC with severe forms of COPD. Clinical case 2 shows that emergency replacement of the patient's respiratory function has significant difficulties in terms of treatment and prognosis of the course of the disease, and increases the duration of his stay in the intensive care unit.
- Open Access
- 25 February 2025
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 10 (1) , 56-62
Cellular Immunity in Patients With Small Cell Lung Cancer in Presence and Absence of Circulating Tumor Cells
Background: Circulating tumor cells (CTCs) play an important role in hematogenous metastasis of malignant tumors. Small cell lung cancer (SCLC) is the most aggressive form of lung cancer with the highest number of detected CTCs.Objective: To evaluate the presence and number of CTCs as an immunosuppression factor in SCLC.Materials and methods: In 30 patients with stage III-IV SCLC, CTCs were detected using the CellSearch system (Veridex LLC, Belgium) before treatment. The participants were divided into groups based on presence of CTCs. Flow cytometry was used to assess T- and natural killer (NK)-cellular components of the immune system and revealed that the CTC presence in patients with SCLCwas accompanied by low levels of NK cells expressing CD335+, granzyme B, and perforin and lower levels of helper T cells with markers of early activation (CD38 and CD69). Lower levels of CD8+CD69+ activated cytotoxic T cells were observed with the highest level of CTCs (>50). Thus, a decrease in the quantitative and functional parameters of T and NK cells in presence of CTCs can be regarded as one of the immunosuppression factors in patients with SCLC.Results: The presence of CTCs, regardless of their number in the blood of patients with SCLC, is characterized by suppression of the innate immune system: decreased functional activity of NK cells, which, even with the preservedtotal number of NK cells, leads to a decrease in their antitumor potential and is often observed in case of widespread metastases. A similar pattern was noted in the analysis of the adaptive immune system, namely, the T cells.Conclusions: As with other malignant tumors, the presence of CTCs in patients with SCLC can be regarded as one of the immunosuppression factors.
- 25 February 2025
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 10 (1) , 56-62
Open AccessCellular Immunity in Patients With Small Cell Lung Cancer in Presence and Absence of Circulating Tumor Cells
Background: Circulating tumor cells (CTCs) play an important role in hematogenous metastasis of malignant tumors. Small cell lung cancer (SCLC) is the most aggressive form of lung cancer with the highest number of detected CTCs.Objective: To evaluate the presence and number of CTCs as an immunosuppression factor in SCLC.Materials and methods: In 30 patients with stage III-IV SCLC, CTCs were detected using the CellSearch system (Veridex LLC, Belgium) before treatment. The participants were divided into groups based on presence of CTCs. Flow cytometry was used to assess T- and natural killer (NK)-cellular components of the immune system and revealed that the CTC presence in patients with SCLCwas accompanied by low levels of NK cells expressing CD335+, granzyme B, and perforin and lower levels of helper T cells with markers of early activation (CD38 and CD69). Lower levels of CD8+CD69+ activated cytotoxic T cells were observed with the highest level of CTCs (>50). Thus, a decrease in the quantitative and functional parameters of T and NK cells in presence of CTCs can be regarded as one of the immunosuppression factors in patients with SCLC.Results: The presence of CTCs, regardless of their number in the blood of patients with SCLC, is characterized by suppression of the innate immune system: decreased functional activity of NK cells, which, even with the preservedtotal number of NK cells, leads to a decrease in their antitumor potential and is often observed in case of widespread metastases. A similar pattern was noted in the analysis of the adaptive immune system, namely, the T cells.Conclusions: As with other malignant tumors, the presence of CTCs in patients with SCLC can be regarded as one of the immunosuppression factors.
- 4 February 2025
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 1,p. 68-73
Resection of sternum body with anterior segments of ribs II—III and bone replacement with individual titanium implant
Metastatic breast cancer is the most common malignancy and urgent problem due to high mortality. This fact emphasizes the need for development of innovative surgical approaches. Innovative approaches, including 3D modeling, provide unique opportunities for accurate reconstruction of the sternum. This method promises significant progress in individualized treatment with higher effectiveness and survival. We present resection of sternum body with anterior segments of ribs II—III and bone replacement with individual titanium implant in a patient with metastatic breast cancer.
- 4 February 2025
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 1,p. 68-73
Resection of sternum body with anterior segments of ribs II—III and bone replacement with individual titanium implant
Metastatic breast cancer is the most common malignancy and urgent problem due to high mortality. This fact emphasizes the need for development of innovative surgical approaches. Innovative approaches, including 3D modeling, provide unique opportunities for accurate reconstruction of the sternum. This method promises significant progress in individualized treatment with higher effectiveness and survival. We present resection of sternum body with anterior segments of ribs II—III and bone replacement with individual titanium implant in a patient with metastatic breast cancer.
- Open Access
- 4 December 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (4) , 46-57
Features of the course of non‑small cell lung cancer and the percentage of lymphocytes in the blood of patients who had recovered from COVID‑19
Purpose of the study. This study aimed to identify the characteristics of the course of cell lung cancer (LC) and the information content of the indicators of the adaptation status of patients of different sexes who had COVID‑19, confirmed by PCR diagnostic results before the start of antitumor treatment. Patients and methods. We have studied traditional clinical and laboratory parameters, and the white blood cell count in patients with non‑small cell LC st. I–III, men (59) and women (32) aged 36–75 years. The main groups included 32 men and 16 women who had COVID‑19, confirmed by real‑time PCR, 2–9 months before hospitalization. Patients in the control groups denied having a history of diagnosed COVID‑19. Before the start of antitumor treatment, the percentage of lymphocytes in the blood was assessed. Cases of LC progression and mortality within a year after antitumor treatment were noted. Results. In men of the main group a 2.7‑fold increase (p < 0.05) in cases of early lung cancer stagings with a simultaneous tendency towards an increase in the number of incidences of metastasizing and mortality within a year after inpatient treatment in comparison with control indexes were observed. Signs of disease severity worsening and a decrease in the effectiveness of treatment were observed without significant changes in the ratio of the patients with tumors of various stagings in female patients. In patients of the main groups, a disturbance of the correspondence between the percentage of lymphocytes and the prevalence and dynamics of the malignant process was noted. In men of the main group who died within the first year after the end of antitumor treatment, the percentage of lymphocytes before the start of treatment reached 28–45 %, corresponding to antistress adaptational reactions, 4 times more often than in the control group (p < 0.01) Conclusion. COVID‑19 flow before the start of LC treatment contributes to a decrease in the body's antitumor resistance and a violation of the informativeness of the percentage of blood lymphocytes as an indicator of adaptation status. Changes depend on sex. In women, the observed changes reflected an aggravation of the malignant process and systemic disorders, as well as a decrease in the effectiveness of treatment. In men, a sharp increase in the number of cases of one year mortality with high percentage of blood lymphocytes before the start of treatment, as well as the number of cases of early‑ stage LC, indicates a more significant change in the state of lymphocytes compared to that observed only in LC, as well as the possibility of acceleration of the transition of precancerous cells into malignant process in the lungs under the influence of a previous coronavirus infection.
- 4 December 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (4) , 46-57
Open AccessFeatures of the course of non‑small cell lung cancer and the percentage of lymphocytes in the blood of patients who had recovered from COVID‑19
Purpose of the study. This study aimed to identify the characteristics of the course of cell lung cancer (LC) and the information content of the indicators of the adaptation status of patients of different sexes who had COVID‑19, confirmed by PCR diagnostic results before the start of antitumor treatment. Patients and methods. We have studied traditional clinical and laboratory parameters, and the white blood cell count in patients with non‑small cell LC st. I–III, men (59) and women (32) aged 36–75 years. The main groups included 32 men and 16 women who had COVID‑19, confirmed by real‑time PCR, 2–9 months before hospitalization. Patients in the control groups denied having a history of diagnosed COVID‑19. Before the start of antitumor treatment, the percentage of lymphocytes in the blood was assessed. Cases of LC progression and mortality within a year after antitumor treatment were noted. Results. In men of the main group a 2.7‑fold increase (p < 0.05) in cases of early lung cancer stagings with a simultaneous tendency towards an increase in the number of incidences of metastasizing and mortality within a year after inpatient treatment in comparison with control indexes were observed. Signs of disease severity worsening and a decrease in the effectiveness of treatment were observed without significant changes in the ratio of the patients with tumors of various stagings in female patients. In patients of the main groups, a disturbance of the correspondence between the percentage of lymphocytes and the prevalence and dynamics of the malignant process was noted. In men of the main group who died within the first year after the end of antitumor treatment, the percentage of lymphocytes before the start of treatment reached 28–45 %, corresponding to antistress adaptational reactions, 4 times more often than in the control group (p < 0.01) Conclusion. COVID‑19 flow before the start of LC treatment contributes to a decrease in the body's antitumor resistance and a violation of the informativeness of the percentage of blood lymphocytes as an indicator of adaptation status. Changes depend on sex. In women, the observed changes reflected an aggravation of the malignant process and systemic disorders, as well as a decrease in the effectiveness of treatment. In men, a sharp increase in the number of cases of one year mortality with high percentage of blood lymphocytes before the start of treatment, as well as the number of cases of early‑ stage LC, indicates a more significant change in the state of lymphocytes compared to that observed only in LC, as well as the possibility of acceleration of the transition of precancerous cells into malignant process in the lungs under the influence of a previous coronavirus infection.
- Open Access
- 14 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 38-45
A case of a fifteen-year-old patient suffering from rare adenocystic lung carcinoma bronchoplastic surgery
Adenoid cystic carcinoma of the lung is a relatively rare malignant tumor, accounting for 0.04–0.2 % of all primary malignant tumors of the respiratory system. This carcinoma can occur at any age, but it is more common in the 40–60 age group and usually in women. The main treatment method for adenoid cystic carcinoma is surgical. Since tumors of this histological form are often centrally located, options for bronchoplastic operations are considered. In childhood, adenoid cystic carcinoma is extremely rare, and performing bronchoplastic lobectomies in children is associated with several difficulties, such as the smaller diameter of the bronchi compared to adult patients, complicating surgical intervention and subsequent rehabilitation. This clinical case demonstrates the experience of performing a bronchoplastic operation on a 15-year-old patient at the Department of Thoracic Oncology of the National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation. The patient was hospitalized complaining of prolonged cough, shortness of breath, and chest pain. Adenoid cystic carcinoma of the central type was identified during diagnostics, which included bronchoscopy, computed tomography, and biopsy. The surgical intervention involved performing a bronchoplastic lobectomy, during which the affected lobe of the lung was removed with resection and reconstruction of the bronchus. The operation was performed taking into account the anatomical features of the child's body, which required high precision and surgical skills. The postoperative period proceeded without significant complications, and the patient was under the supervision of a multidisciplinary team of specialists.This clinical case provides a detailed description of the results of preoperative diagnostic measures, the stages of the operation, and the postoperative follow-up results. Special attention was paid to the difficulties associated with the small diameter of the bronchi in children, which required the use of specialized instruments and techniques. The importance of using modern diagnostic and treatment methods, as well as close interdisciplinary interaction, is emphasized for a successful treatment outcome.The experience of performing such operations in childhood is extremely important for improving the quality and safety of surgical treatment of adenoid cystic carcinoma and other rare tumors in children. Further observations will be described in stages.
- 14 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 38-45
Open AccessA case of a fifteen-year-old patient suffering from rare adenocystic lung carcinoma bronchoplastic surgery
Adenoid cystic carcinoma of the lung is a relatively rare malignant tumor, accounting for 0.04–0.2 % of all primary malignant tumors of the respiratory system. This carcinoma can occur at any age, but it is more common in the 40–60 age group and usually in women. The main treatment method for adenoid cystic carcinoma is surgical. Since tumors of this histological form are often centrally located, options for bronchoplastic operations are considered. In childhood, adenoid cystic carcinoma is extremely rare, and performing bronchoplastic lobectomies in children is associated with several difficulties, such as the smaller diameter of the bronchi compared to adult patients, complicating surgical intervention and subsequent rehabilitation. This clinical case demonstrates the experience of performing a bronchoplastic operation on a 15-year-old patient at the Department of Thoracic Oncology of the National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation. The patient was hospitalized complaining of prolonged cough, shortness of breath, and chest pain. Adenoid cystic carcinoma of the central type was identified during diagnostics, which included bronchoscopy, computed tomography, and biopsy. The surgical intervention involved performing a bronchoplastic lobectomy, during which the affected lobe of the lung was removed with resection and reconstruction of the bronchus. The operation was performed taking into account the anatomical features of the child's body, which required high precision and surgical skills. The postoperative period proceeded without significant complications, and the patient was under the supervision of a multidisciplinary team of specialists.This clinical case provides a detailed description of the results of preoperative diagnostic measures, the stages of the operation, and the postoperative follow-up results. Special attention was paid to the difficulties associated with the small diameter of the bronchi in children, which required the use of specialized instruments and techniques. The importance of using modern diagnostic and treatment methods, as well as close interdisciplinary interaction, is emphasized for a successful treatment outcome.The experience of performing such operations in childhood is extremely important for improving the quality and safety of surgical treatment of adenoid cystic carcinoma and other rare tumors in children. Further observations will be described in stages.
- Open Access
- 13 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 58-70
The role of tumor stem cells and the immune microenvironment in the pathogenesis of lung cancer: mechanisms of interaction and research prospects
Despite significant advances in the treatment of malignant neoplasms, the issue of therapy resistance mediated by cancer stem cells (CSCs) necessitates the development of new treatment strategies. Studying the role of CSCs and the immune microenvironment in the pathogenesis of cancer, particularly non-small cell lung cancer (NSCLC), is a pressing issue in modern oncology. This paper is based on an extensive analysis of recent research and aims to study the mechanisms underlying the development of NSCLC.The origin of CSCs, their markers, and the main signaling pathways involved in regulating their activity are considered. Special attention is paid to the influence of CSCs on the progression of lung cancer and the mechanisms underlying their therapy-mediated resistance. Various approaches to treating lung cancer targeting CSCs, focusing on targeted therapy aimed at specific molecular targets, are highlighted.The important role of the tumor immune microenvironment in the pathogenesis of lung cancer and its impact on CSCs is emphasized. Mechanisms of immune response regulation in tumors and the potential use of immunotherapy to improve lung cancer treatment outcomes are discussed. The article also reviews modern diagnostic and treatment methods, including molecular-genetic and immunohistochemical approaches.This paper work represents a review of current knowledge on the mechanisms of lung cancer development and is significant for understanding tumor biology and developing new treatment methods. The need for an interdisciplinary approach and comprehensive use of modern diagnostic and therapeutic methods to improve the prognosis and survival rates of NSCLC patients is emphasized. Special attention is given to the prospects of using combined therapeutic approaches, including targeted drugs and immunotherapy, aimed at suppressing CSC activity and modifying the tumor microenvironment.In conclusion, a deep understanding of the molecular mechanisms regulating CSC activity and their interaction with the tumor microenvironment opens new opportunities for developing effective treatment strategies. This review underscores the need for further research in this area to ensure more successful treatment and improved quality of life for lung cancer patients.
- 13 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 58-70
Open AccessThe role of tumor stem cells and the immune microenvironment in the pathogenesis of lung cancer: mechanisms of interaction and research prospects
Despite significant advances in the treatment of malignant neoplasms, the issue of therapy resistance mediated by cancer stem cells (CSCs) necessitates the development of new treatment strategies. Studying the role of CSCs and the immune microenvironment in the pathogenesis of cancer, particularly non-small cell lung cancer (NSCLC), is a pressing issue in modern oncology. This paper is based on an extensive analysis of recent research and aims to study the mechanisms underlying the development of NSCLC.The origin of CSCs, their markers, and the main signaling pathways involved in regulating their activity are considered. Special attention is paid to the influence of CSCs on the progression of lung cancer and the mechanisms underlying their therapy-mediated resistance. Various approaches to treating lung cancer targeting CSCs, focusing on targeted therapy aimed at specific molecular targets, are highlighted.The important role of the tumor immune microenvironment in the pathogenesis of lung cancer and its impact on CSCs is emphasized. Mechanisms of immune response regulation in tumors and the potential use of immunotherapy to improve lung cancer treatment outcomes are discussed. The article also reviews modern diagnostic and treatment methods, including molecular-genetic and immunohistochemical approaches.This paper work represents a review of current knowledge on the mechanisms of lung cancer development and is significant for understanding tumor biology and developing new treatment methods. The need for an interdisciplinary approach and comprehensive use of modern diagnostic and therapeutic methods to improve the prognosis and survival rates of NSCLC patients is emphasized. Special attention is given to the prospects of using combined therapeutic approaches, including targeted drugs and immunotherapy, aimed at suppressing CSC activity and modifying the tumor microenvironment.In conclusion, a deep understanding of the molecular mechanisms regulating CSC activity and their interaction with the tumor microenvironment opens new opportunities for developing effective treatment strategies. This review underscores the need for further research in this area to ensure more successful treatment and improved quality of life for lung cancer patients.
- Open Access
- 13 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 14-19
Research on the expression of E-cadherin in lung cancer tumors with different histological structures
Purpose of the study. To conduct a comparative analysis of E-cadherin expression in inoperable patients with non-small cell lung cancer (NSCLC) cells and with different survival rates.Materials and methods. The study included 96 patients with inoperable NSCLC: 84 (87.5 %) men and 12 (12.5 %) women, whose average age was 62.4 ± 0.68 years. Squamous cell carcinoma (SCC) was diagnosed in 78 (81.25 %) patients, and adenocarcinoma (AC) with a tumor differentiation grade of G2-G3 in 18 (18.75 %). The patients were treated and monitored at the National Medical Research Centre for Oncology. The expression of cadherins was determined in the tumor cells of the biopsy specimens. The obtained data have been processed using the Statistica 13.0 program (StatSoftInc., USA). The studied data have been checked for compliance with the normal distribution using the Shapiro-Wilk criterion.Results. The following distribution of patients with NSCLC was noted: IIA – 2 (2.1 %), IIB – 14 (14.6 %), IIIA – 51 (53.1 %), IIIB – 29 (30.2 %), i. e. the frequency of stage III is higher than stage II (83.3 % (n = 80) versus 16.7 % (n = 16), p < 0.001). Fatal outcome occurred in the SCC group within 1 year in 28 patients, within 1 to 2 years – in 30, 20 patients survived for 3 years or more. For AC, these figures were 6,5 and 7 respectively. The analysis revealed that E-cadherin expression was noted in both squamous cell carcinoma and lung adenocarcinoma: Me 55 [LQ 37; UQ 65] and Me 50 [LQ 40; UQ 70], respectively.Conclusions. 1. The analysis revealed that E-cadherin expression was observed in both squamous cell carcinoma and lung adenocarcinomas without statistically significant differences between the compared groups (p = 0.25). 2. Statistically significant differences in the levels of E-cadherin expression were noted in the biopsy samples of the 2 groups only with survival up to 1 year and up to 3 years or more (p < 0.05).
- 13 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 14-19
Open AccessResearch on the expression of E-cadherin in lung cancer tumors with different histological structures
Purpose of the study. To conduct a comparative analysis of E-cadherin expression in inoperable patients with non-small cell lung cancer (NSCLC) cells and with different survival rates.Materials and methods. The study included 96 patients with inoperable NSCLC: 84 (87.5 %) men and 12 (12.5 %) women, whose average age was 62.4 ± 0.68 years. Squamous cell carcinoma (SCC) was diagnosed in 78 (81.25 %) patients, and adenocarcinoma (AC) with a tumor differentiation grade of G2-G3 in 18 (18.75 %). The patients were treated and monitored at the National Medical Research Centre for Oncology. The expression of cadherins was determined in the tumor cells of the biopsy specimens. The obtained data have been processed using the Statistica 13.0 program (StatSoftInc., USA). The studied data have been checked for compliance with the normal distribution using the Shapiro-Wilk criterion.Results. The following distribution of patients with NSCLC was noted: IIA – 2 (2.1 %), IIB – 14 (14.6 %), IIIA – 51 (53.1 %), IIIB – 29 (30.2 %), i. e. the frequency of stage III is higher than stage II (83.3 % (n = 80) versus 16.7 % (n = 16), p < 0.001). Fatal outcome occurred in the SCC group within 1 year in 28 patients, within 1 to 2 years – in 30, 20 patients survived for 3 years or more. For AC, these figures were 6,5 and 7 respectively. The analysis revealed that E-cadherin expression was noted in both squamous cell carcinoma and lung adenocarcinoma: Me 55 [LQ 37; UQ 65] and Me 50 [LQ 40; UQ 70], respectively.Conclusions. 1. The analysis revealed that E-cadherin expression was observed in both squamous cell carcinoma and lung adenocarcinomas without statistically significant differences between the compared groups (p = 0.25). 2. Statistically significant differences in the levels of E-cadherin expression were noted in the biopsy samples of the 2 groups only with survival up to 1 year and up to 3 years or more (p < 0.05).
- Open Access
- 21 February 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (1) , 42-51
Characteristics of anesthetic and surgical tactics in treatment of a patient with a giant thyroid mass in a cancer center (clinical case)
This paper describes an example of radical surgical treatment of a patient with a giant retrosternal goiter complicated by compression of the organs of the neck and mediastinum. Considering all the risks and possible complications, we should take into account the fact that enlarged thyroid (T) body with retrosternal location can cause displacement and stenosis of the trachea and esophagus, and dislocation of large vessels and nerves of the mediastinum. This anatomical specificity is an imminent threat to successful treatment, and it also carries a certain risk of asphyxia and sudden death of the patient. In this clinical case, radical surgical treatment in this patient included sequential mobilization in two pleural cavities, and then the total removal of T through the traditional surgical access. The anesthetic complexity to support the surgical intervention involved both difficult intubation due to tracheal stenosis, and also the required separate ventilation of the lungs to visualize anatomical structures and mobilize a multinodular formation in two pleural cavities. Standard methods of artificial lung ventilation could be ineffective and even dangerous in this case due to the location and size of the tumor. We focused our attention on high-frequency ventilation (HFV), the best method of respiratory support during surgeries for tracheal and bronchial pathologies. The main task of the anesthetic team in this clinical case was to prevent the development of hypercapnia and hypoxia during intubation of the stenotic tracheal segment, and then adequate ventilation of the lungs with reduced area of proper gas exchange due to bilateral surgical pneumothorax. Thus, the full treatment was carried out due to the only safe method of compensating lung ventilation with anesthesia by HFV. The applied HFV method creates an adequate gas exchange in the lungs due to the small ventilation volume and high frequency of respiratory cycles per minute. HFV both prevented the development of threatening complications during intubation of the stenotic tracheal area and ensured an adequate gas exchange during successive thoracoscopic stages of thyroid tumor mobilization.
- 21 February 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (1) , 42-51
Open AccessCharacteristics of anesthetic and surgical tactics in treatment of a patient with a giant thyroid mass in a cancer center (clinical case)
This paper describes an example of radical surgical treatment of a patient with a giant retrosternal goiter complicated by compression of the organs of the neck and mediastinum. Considering all the risks and possible complications, we should take into account the fact that enlarged thyroid (T) body with retrosternal location can cause displacement and stenosis of the trachea and esophagus, and dislocation of large vessels and nerves of the mediastinum. This anatomical specificity is an imminent threat to successful treatment, and it also carries a certain risk of asphyxia and sudden death of the patient. In this clinical case, radical surgical treatment in this patient included sequential mobilization in two pleural cavities, and then the total removal of T through the traditional surgical access. The anesthetic complexity to support the surgical intervention involved both difficult intubation due to tracheal stenosis, and also the required separate ventilation of the lungs to visualize anatomical structures and mobilize a multinodular formation in two pleural cavities. Standard methods of artificial lung ventilation could be ineffective and even dangerous in this case due to the location and size of the tumor. We focused our attention on high-frequency ventilation (HFV), the best method of respiratory support during surgeries for tracheal and bronchial pathologies. The main task of the anesthetic team in this clinical case was to prevent the development of hypercapnia and hypoxia during intubation of the stenotic tracheal segment, and then adequate ventilation of the lungs with reduced area of proper gas exchange due to bilateral surgical pneumothorax. Thus, the full treatment was carried out due to the only safe method of compensating lung ventilation with anesthesia by HFV. The applied HFV method creates an adequate gas exchange in the lungs due to the small ventilation volume and high frequency of respiratory cycles per minute. HFV both prevented the development of threatening complications during intubation of the stenotic tracheal area and ensured an adequate gas exchange during successive thoracoscopic stages of thyroid tumor mobilization.